Clinicians who suspect their patients may have immune thrombocytopenia (ITP) should look for platelet autoantibodies both in the bloodstream and the bone marrow, new research suggests. "Diagnosing ITP ... The Japanese pharma is currently investigating mezagitamab’s potential in two late-stage autoimmune programmes.
Fierce Biotech: In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, providing further proof of the modality’s promise in the disease area as a ... In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient Morning Overview on MSN: CAR-T therapy sends 3 autoimmune diseases into remission in 1 patient A woman in her thirties who was dependent on blood transfusions and unresponsive to every standard treatment for her three overlapping autoimmune diseases is now symptom-free and off all medications ... WELLESLEY HILLS, Mass., (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...
